Product Information
METFORMIN HCL ER 750 MG TABLET is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.0548 per EA under NDC 82009011801. Its NADAC has been published 141 times since Oct 18, 2023.
Strength
750 mg/1
Manufacturer
Quallent Pharmaceuticals Health LLCNDC
82009011801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209313On Market Since
7/25/2023
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL ER 750 MG TABLET has been published 141 times since Oct 18, 2023, and over the history we have for it it has declined 19.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0548 per EA |
|---|---|
| All-time high | $0.0731 (Oct 16, 2024) |
| All-time low | $0.0526 (Sep 17, 2025) |
| 52-week high | $0.0566 |
| 52-week low | $0.0526 |
| Median price | $0.0564 |
| Average price | $0.0597 |
| Largest weekly change | -20.8% (Jul 17, 2024) |
| Weeks tracked | 141 |
| Tracking since | Oct 18, 2023 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METFORMIN HCL ER 750 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL ER 750 MG TABLET, manufactured by Quallent Pharmaceuticals Health LLC, is $0.0548 per EA (NDC 82009011801), effective Jun 24, 2026.
How has the price of METFORMIN HCL ER 750 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL ER 750 MG TABLET has declined 19.1%. It has been tracked across 141 weekly CMS publications since Oct 18, 2023.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL ER 750 MG TABLET?
Since Oct 18, 2023, the NADAC for METFORMIN HCL ER 750 MG TABLET has ranged from a low of $0.0526 (Sep 17, 2025) to a high of $0.0731 (Oct 16, 2024), with a median of $0.0564 per EA.
Are there cheaper alternatives to METFORMIN HCL ER 750 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as METFORMIN HCL ER 750 MG TABLET, but none are currently priced below it.
Who manufactures METFORMIN HCL ER 750 MG TABLET?
METFORMIN HCL ER 750 MG TABLET (NDC 82009011801) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification